Articles written for the GLP list the source as Genetic Literacy Project. All other articles were written for the sources noted with excerpts provided by the GLP.
4-9-2019 fda approves nasal spray antidepressant spravato gupta pkg newday vpx exlarge

Why esketamine will force doctors to rethink office visits for depressed patients

STAT | 
The Food and Drug Administration approved esketamine (Spravato) for treatment-resistant depression to be administered under physician supervision. It’s a derivative of ...